Research Results
- Precision Medicine for Depression
- Research Tools & Papers
- Improving Clinical Practice
- Information for Patients
- Previous Study Results
⁍ Predicting Treatment Outcomes in Major Depressive Disorder
⁍ Using Neuroimaging to Predict Treatment Outcomes in Major Depressive Disorder
Identification of biomakers predictive of outcome to treatment with psychotherapy or medication in patients with major depressive disorder.
⁍ Toward a neuroimaging treatment selection biomarker for major depressive disorder.
⁍ Insula Metabolic Activity as a Predictor of Outcome to Psychotherapy and Medication Treatments for Depression.
⁍ Pretreatment brain states identify likely nonresponse to standard treatments for depression.
⁍ Predictors of remission in depression to individual and combined treatments (PReDICT)
⁍ Prediction of treatment outcome in major depression
⁍ Using Neuroimaging to Predict Treatment Outcomes in Major Depressive Disorder
Identification of biomakers predictive of outcome to treatment with psychotherapy or medication in patients with major depressive disorder.
⁍ Toward a neuroimaging treatment selection biomarker for major depressive disorder.
⁍ Insula Metabolic Activity as a Predictor of Outcome to Psychotherapy and Medication Treatments for Depression.
⁍ Pretreatment brain states identify likely nonresponse to standard treatments for depression.
⁍ Predictors of remission in depression to individual and combined treatments (PReDICT)
⁍ Prediction of treatment outcome in major depression
⁍ Development of a Spanish-speaking depression research site.
⁍ The Emory Treatment Resistance Interview for PTSD (E-TRIP)
⁍ Should Sensitive Information From Clinical Trials Be Included in Electronic Medical Records?
⁍ Enhancing Informed Consent in Clinical Trials and Exploring Resistances to Disclosing Adverse Clinical Trial Results
⁍ Impact of HIPAA regulations on research participation
⁍ Exercise during clinical trials for depression
⁍ Investigators’ interventions during clinical trials
⁍ Ethical defense of placebo controls in clinical trials
⁍ Importance of academic sites for clinical trials
⁍ Including psychiatric research information in electronic medical records
⁍ The Emory Treatment Resistance Interview for PTSD (E-TRIP)
⁍ Should Sensitive Information From Clinical Trials Be Included in Electronic Medical Records?
⁍ Enhancing Informed Consent in Clinical Trials and Exploring Resistances to Disclosing Adverse Clinical Trial Results
⁍ Impact of HIPAA regulations on research participation
⁍ Exercise during clinical trials for depression
⁍ Investigators’ interventions during clinical trials
⁍ Ethical defense of placebo controls in clinical trials
⁍ Importance of academic sites for clinical trials
⁍ Including psychiatric research information in electronic medical records
⁍ Ten ways to improve the treatment of depression and anxiety in adults
⁍ Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review
⁍ Panic Disorder: Break the Fear Cycle
⁍ Contemporary Diagnosis and Management of Anxiety Disorders (Book)
⁍ Impact of HIPAA regulations on research participation
⁍ Review of Nutritional Supplements for Bipolar Depression
⁍ Treating Anxiety in Bipolar Depression
⁍ Combination Psychotherapy and Medication for Depression
⁍ Treatment of Bipolar Mania in Outpatient Depression
⁍ Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review
⁍ Panic Disorder: Break the Fear Cycle
⁍ Contemporary Diagnosis and Management of Anxiety Disorders (Book)
⁍ Impact of HIPAA regulations on research participation
⁍ Review of Nutritional Supplements for Bipolar Depression
⁍ Treating Anxiety in Bipolar Depression
⁍ Combination Psychotherapy and Medication for Depression
⁍ Treatment of Bipolar Mania in Outpatient Depression
⁍ Radio Interviews about Anxiety and Depression
⁍ Web MD: Starting and stopping antidepressants
Men and Depression
⁍ Male depression "set to increase".
Placebos and Antidepressant Medications
⁍ House Call with Dr. Sanjay Gupta
⁍ Web MD: Starting and stopping antidepressants
Men and Depression
⁍ Male depression "set to increase".
Placebos and Antidepressant Medications
⁍ House Call with Dr. Sanjay Gupta
⁍ The combination of triiodothyronine (T3) and sertraline is not superior to sertraline monotherapy in the treatment of major depressive disorder
⁍ Modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness
⁍ Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder.
⁍ Mediators of sexual functioning and marital quality in chronically depressed adults with and without a history of childhood sexual abuse.
⁍ Impact of HIPAA regulations on research participation
⁍ Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
⁍ Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.
⁍ Demonstrated the potential value of tiagabine (Gabatril) in the treatment of social anxiety disorder
⁍ Contributed to studies demonstrating the importance of maintenance medication for staying depression-free among patients with recurrent depression.
⁍ Modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness
⁍ Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder.
⁍ Mediators of sexual functioning and marital quality in chronically depressed adults with and without a history of childhood sexual abuse.
⁍ Impact of HIPAA regulations on research participation
⁍ Efficacy and safety of desvenlafaxine 50 mg/d in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
⁍ Symptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placebo.
⁍ Demonstrated the potential value of tiagabine (Gabatril) in the treatment of social anxiety disorder
⁍ Contributed to studies demonstrating the importance of maintenance medication for staying depression-free among patients with recurrent depression.
"Precision Medicine" is the identification of biological and clinical characteristics of a patient that indicate which specific treatment is most likely to benefit that particular person.